These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10638863)

  • 1. Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited.
    Peralta V; Cuesta MJ
    Schizophr Res; 1999 Dec; 40(3):245-53. PubMed ID: 10638863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
    Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
    J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia: a multinational study. Units of analysis, groups of units, and the psychopathology of patient groups.
    Public Health Pap; 1975; (63):46-78. PubMed ID: 1242839
    [No Abstract]   [Full Text] [Related]  

  • 6. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA; Oosthuizen PP; Joubert AF; Roberts MC; Stein DJ
    J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative symptoms and neuroleptics in catatonic schizophrenia.
    Salokangas RK; Honkonen T; Stengård E; Koivisto AM; Hietala J
    Schizophr Res; 2003 Jan; 59(1):73-6. PubMed ID: 12413645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population.
    Bush G; Petrides G; Francis A
    Schizophr Res; 1997 Oct; 27(1):83-92. PubMed ID: 9373898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-induced catatonia: case report.
    Johnson GC; Manning DE
    J Clin Psychiatry; 1983 Aug; 44(8):310-2. PubMed ID: 6874654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in first-episode schizophrenia.
    Koreen AR; Siris SG; Chakos M; Alvir J; Mayerhoff D; Lieberman J
    Am J Psychiatry; 1993 Nov; 150(11):1643-8. PubMed ID: 8105706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor, volitional and behavioural disorders in schizophrenia. 2: The 'conflict of paradigms' hypothesis.
    McKenna PJ; Lund CE; Mortimer AM; Biggins CA
    Br J Psychiatry; 1991 Mar; 158():328-36. PubMed ID: 2036530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase.
    Ungvari GS; Leung SK; Ng FS; Cheung HK; Leung T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):27-38. PubMed ID: 15610942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia with prominent catatonic features ('catatonic schizophrenia') III. Latent class analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Lee E; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):81-5. PubMed ID: 18992297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exacerbation of catatonic symptoms in neuroleptic therapy].
    Bräunig P; Krüger S; Höffler J
    Nervenarzt; 1995 May; 66(5):379-82. PubMed ID: 7609820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
    Menard ML; Yagoubi F; Drici M; Lavrut T; Askenazy F
    Encephale; 2013 May; 39 Suppl 1():S29-35. PubMed ID: 23219595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative symptoms, depression, and parkinsonian symptoms in chronic, hospitalised schizophrenic patients.
    Perenyi A; Norman T; Hopwood M; Burrows G
    J Affect Disord; 1998 Mar; 48(2-3):163-9. PubMed ID: 9543206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):462-8. PubMed ID: 17188791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia.
    Kopala LC; Caudle C
    J Psychopharmacol; 1998; 12(3):314-7. PubMed ID: 10958259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.